RGLS Regulus Therapeutics Inc

Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/04/2012
Outstanding shares:  87,047,832
Average volume:  1,466,877
Market cap:   $31,772,459
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75915K200
ISIN:        US75915K2006
Valuation   (See tab for details)
PE ratio:   -1.35
PB ratio:   1.02
PS ratio:   3.18
Return on equity:   -75.82%
Net income %:   -219.86%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy